药物和食物干扰莱沃西的生物可用性:系统性审查
Hanqing Liu1, Man Lu1, Jiawei Hu1
1Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, People's Republic of China.
Therapeutics and clinical risk management
|June 29, 2023
概括
许多常见的药物和食物可以干扰勒沃西的吸收,影响治疗的有效性. 了解这些相互作用对于优化勒沃西治疗和患者的治疗结果至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
- 药物相互作用 药物相互作用
背景情况:
- 利沃甲状腺素是一种广泛处方的甲状腺功能低下症药物.
- 它的生物可用性可能会受到不同物质同时摄入的显著影响.
- 了解这些相互作用对于有效的甲状腺激素替代疗法至关重要.
研究的目的:
- 系统地审查和总结与levothyroxine相互作用的药物,食品和饮料.
- 评估这些相互作用的影响,机制和潜在的治疗方法.
- 为了提高levothyroxine治疗的临床意识和管理.
主要方法:
- 通过使用多个数据库 (Web of Science,Embase,PubMed,Cochrane Library) 进行了一次系统的文献审查.
- 包括了研究Levothyroxine与干扰物质的有效性的人类研究.
- 使用NHLBI和JBI的批判性评估工具来评估研究质量.
主要成果:
- 包括107篇文章,包括128项研究,确定了与众多药物 (例如,铁,PPI,抗药) 以及一些食品/饮料的相互作用.
- 机制包括直接复杂化,化,改变的甲状腺素结合型球蛋白和加速的催化.
- 剂量调整,分开使用或特定配方 (液体,软凝) 可以减轻相互作用.
结论:
- 许多药物和饮食成分可以损害levothyroxine的生物可用性.
- 临床医生,患者和制药公司必须意识到潜在的相互作用.
- 需要进一步进行高质量的研究,以巩固有关机制和治疗方法的证据.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
4.8K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.8K
Factors Influencing Drug Absorption: Presystemic Elimination
267
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
267
Factors Influencing Drug Absorption: Disease States and Pharmacology
593
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
593
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Factors Influencing Bioavailability: First-Pass Elimination
6.5K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.5K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
235
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
235


